These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 27629931)

  • 21. Epigenome-modifying tools in asthma.
    Brook PO; Perry MM; Adcock IM; Durham AL
    Epigenomics; 2015; 7(6):1017-32. PubMed ID: 26479310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. At the tipping point for epigenetic therapies in cancer.
    Jones PA
    J Clin Invest; 2014 Jan; 124(1):14-6. PubMed ID: 24382384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Therapies and Potential Drugs for Treating Human Cancer.
    Lin SQ; Li X
    Curr Drug Targets; 2020; 21(11):1068-1083. PubMed ID: 32209040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy.
    Myasoedova VA; Sukhorukov V; Grechko AV; Zhang D; Romanenko E; Orekhov V; Orekhov AN
    Curr Pharm Des; 2019; 25(6):635-641. PubMed ID: 30950345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Techniques to study epigenetic control and the epigenome in parasites.
    Nardelli SC; Ting LM; Kim K
    Methods Mol Biol; 2015; 1201():177-91. PubMed ID: 25388114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatin, cancer and drug therapies.
    Cortez CC; Jones PA
    Mutat Res; 2008 Dec; 647(1-2):44-51. PubMed ID: 18691602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The promise and failures of epigenetic therapies for cancer treatment.
    Bojang P; Ramos KS
    Cancer Treat Rev; 2014 Feb; 40(1):153-69. PubMed ID: 23831234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer.
    Franci G; Miceli M; Altucci L
    Epigenomics; 2010 Dec; 2(6):731-42. PubMed ID: 22122079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.
    Takeshima H; Wakabayashi M; Hattori N; Yamashita S; Ushijima T
    Carcinogenesis; 2015 Feb; 36(2):192-201. PubMed ID: 25477340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Therapeutics: A New Weapon in the War Against Cancer.
    Ahuja N; Sharma AR; Baylin SB
    Annu Rev Med; 2016; 67():73-89. PubMed ID: 26768237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic alterations in cancer.
    Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epigenetics as a novel therapeutic target of cancer].
    Ushijima T; Takeshima H
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1429-35. PubMed ID: 24231695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approaches to target the genome and its epigenome in cancer.
    Chapman-Rothe N; Brown R
    Future Med Chem; 2009 Nov; 1(8):1481-95. PubMed ID: 21426061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studying the epigenome using next generation sequencing.
    Ku CS; Naidoo N; Wu M; Soong R
    J Med Genet; 2011 Nov; 48(11):721-30. PubMed ID: 21825079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analyzing DNA Methylation Patterns During Tumor Evolution.
    Pan H; Elemento O
    Methods Mol Biol; 2018; 1711():27-53. PubMed ID: 29344884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trials with 'epigenetic' drugs: an update.
    Nebbioso A; Carafa V; Benedetti R; Altucci L
    Mol Oncol; 2012 Dec; 6(6):657-82. PubMed ID: 23103179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.